Results 81 - 90 of 1609 : Previous 5 6 7 8 9 10 11 12 13 Next
Is Inhibitex the Perfect Stock?
Finding companies that have all the right stuff can produce winners.
Health-Care News You Can't Afford to Miss
Highlighting the day's health-care stories critical to investors.
1 Reason the Street Should Love Eli Lilly's Earnings
Don't just count the cash, time it.
J&J Wins Blockbuster Approval to Market Xarelto for Stroke Prevention
Peak sales are estimated at nearly $3 billion.
Look here for a clue.
Will Bristol-Myers Squibb Earn or Burn?
Keep your eye on margins.
Why the Street Should Expect Big Things from Bristol-Myers Squibb
Don't just ask, "How much inventory?" Ask, "What kind?"
Hepatitis C drugs take center stage.
When Getting Beat Down Is No Big Deal
Merck has the bulk to take a beatdown.
Let's find out.
Results 81 - 90 of 1609 : Previous 5 6 7 8 9 10 11 12 13 Next